Recursion Pharmaceuticals' stock has been volatile, and is soaring today on news the FDA is planning on phasing out some animal testing, replacing it with AI. The company's Q4 FY24 earnings showed ...

In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.

Recursion Pharmaceuticals' stock jumped after the FDA announced plans to replace the use of animals in drug testing. Recursion is a leader in AI-powered drug discovery and development. It remains ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

At close: April 11 at 4:00:00 PM EDT ...

Potestio, P. (2025) On Two Different Approaches to the Optimal Unemployment Insurance Policy. Modern Economy, 16, 593-615.

这篇文章他提出了一个可以定义现在“人工智能驱动的生命科学研究”的范式是什么的概念： 预测生物学 （ Predictive Biology ） ，几个核心观点是 1.新的生物学研究由机器学习与人工智能来驱动实现，2. 预测一个系统即理解这个系统，而不是执着于创建因果图。3. 涌现论而不是还原论的“认识论”。4. 这一次新的生物学研究范式，会从工业界/营利公司开始，而不是非营利机构和学术界。

The Endless Thirst For More Data As the world became more digitized, it started producing and requiring increasing amounts of data. This poses a problem, as said data is often associated with real ...

University of Geneva is successfully participating in the prestigious ERC (European Research Council) grants scheme which encourages high-level, creative, fundamental research in all scientific ...